Cytel Hosts Inaugural East® Users Group Meeting in October 2011
Software users, developers and clinical study thought-leaders gather in Paris for advanced training and sharing of adaptive trial design experiences
Cambridge, MA, USA - October 13, 2011 - Cytel Inc., a leading provider of adaptive clinical trial design services and biostatistical software, today proudly announced that the first Cytel East® Users Group Meeting will take place in Paris, France, October 13 and 14, 2011.
The event will feature software training workshops and a full day of expert user presentations followed by round table discussions. Participants will have the opportunity to meet their industry colleagues, discuss trends with key opinion leaders and interact with Cytel product developers over demonstrations of the latest trial design software technology.
Cytel President, Co-Founder and driving force behind East, Dr. Cyrus Mehta said of the milestone, “this is our first hosting of the ever-growing community of East users. The forum will provide a feedback loop between clinical trial thought-leaders, the many biostatisticians who depend on East and own software development team.”
East is the widely hailed standard for clinical trial design, simulation and monitoring consistently relied on by virtually every of top biopharmaceutical companies and by regulatory bodies including the US Food and Drug Administration (FDA).
Dr. Mehta concluded, “We’re seeing and hearing time and time again how the clinical trial planners trust East when formulating the best possible statistical design especially for their ever more complex trials, including adaptive approaches for which East is particularly well-suited.”
About the First East Users Group Meeting
The first East Users Group Meeting participants in Paris will be interacting with these featured speakers from industry and academia:
Stuart Pocock - London School of Hygiene and Tropical Medicine
Simon Day - Roche
Loïc Darchy - Sanofi
Marisa Bacchi - Actelion
Cyrus Mehta - Cytel
About Cytel
Cytel Inc. is a leading provider of clinical research services and trial design and analysis software for the biopharmaceutical, medical device and institutional research markets.
All 25 leading global biopharmaceutical companies use Cytel technology to design, simulate and analyze their clinical studies. Pioneers of the supporting statistical methods, every adaptive trial designed by Cytel has been accepted by international regulators.
Interview requests and further information:
Michael Weitz
Marketing Director
617.661.2011
mweitz@cytel.com